Ioneer에 대한 매도 수량은 투자자에게 Ioneer의 주식 하락에 베팅하는 정도를 알려줍니다. 매도 수량 데이터는 2주마다 업데이트됩니다.

Ioneer (NASDAQ:IONR) 주식, 공매도 수량 보고

Ioneer Ltd is a mineral exploration company. The company's focus is on the Rhyolite Ridge Lithium-Boron Project located in Nevada, USA. Geographically, the group has a business presence in Australia and North America. The company's focus is to develop a U.S.-based source of lithium and boron that can be extracted in an environmentally and socially responsible manner, providing two materials that are essential to achieve a sustainable future for the planet.

Loading,Of,Coal,Into,Truck.,Excavator,At,Work,.,Mining

Earnings

News

Commodities

Small Cap

GORO

IONR

KALU

USAU

2024년 4월 16일의 핫한 뉴스: 1. 골드 리소스(NYSE:GORO)가 금 3,557온스과 은 21만 6,535온스의 판매를 포함한 2024년 1분기의 예비 결과를 발표했다. 이는 총 5,965온스의 금 상당량을 의미한다. 이번 분기에 회사는 또한 아연 1,682톤, 구리 264톤, 납 667톤을 판매했다. 

화요일 주요 광업 뉴스: 골드 리소스, 워딩턴 스틸, U.S. 골드, 아이오니어, 카이저

mining shutter

2024년 4월 15일 주요 뉴스: 1. 피드몬트 리튬 (NASDAQ:PLL)는 가스통(Gaston) 카운티의 캐롤라이나 리튬(Carolina Lithium) 프로젝트에 대한 채광 허가에 대해 노스캐롤라이나 환경부로부터 승인을 받니다. 2021년 8월부터 철저한 검토를 거쳐 발급된 이번 허가로, 이 사이트의 건설, 운영 및 복구가 가능해졌다. 

월요일 주요 광업 뉴스: 피드몬트, U.S. 스틸, 아이오니어, 이페리온엑스

Ioneer Ltd

Offerings

LQR House Files For Common Stock Offering Of Up To $25M

Barclays analyst Theresa Chen maintains HF Sinclair (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DINO#NYSE">DINO</a>) with a Equal-Weight and raises the price target from $29 to $32.

Price Target

Analyst Ratings

DINO

Barclays Maintains Equal-Weight on HF Sinclair, Raises Price Target to $32

Life360 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIF#NASDAQ">LIF</a>) affirms FY2025 sales outlook from $450.00 million-$480.00 million to $450.00 million-$480.00 million vs $466.67 million estimate.

Guidance

Life360 Affirms FY2025 Sales Guidance of $450.00M-$480.00M vs $466.67M Est

Lument Finance Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LFT#NYSE">LFT</a>) reported quarterly earnings of $0.08 per share which missed the analyst consensus estimate of $0.09 by 11.11 percent. This is a 20 percent decrease over earnings of $0.10 per share from the same period last year. The company reported quarterly sales of $7.74 million which missed the analyst consensus estimate of $9.51 million by 18.66 percent. This is a 40.47 percent decrease over sales of $12.99 million the same period last year.

Earnings Misses

CORRECTION: Lument Finance Trust Q1 Adj. EPS $0.08 Misses $0.09 Estimate, Sales $7.74M Miss $9.51M Estimate

MicroVision Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MVIS#NASDAQ">MVIS</a>) reported first-quarter financial results after the market close on Monday. Here&#8217;s a rundown <a href="https://www.benzinga.com/pressreleases/25/05/ac45359368/microvision-announces-first-quarter-2025-results">of the report</a>.
<ul class="wp-block-list">
<li>Q1 Revenue: $589,000, versus <a href="http://benzinga.com/quote/mvis/earnings">estimates</a> of $2.25 million</li>
</ul>
<ul class="wp-block-list">
<li>Q1 Adjusted Loss: 10 cents, versus estimates of seven cents</li>
</ul>
Total operating expenses were down 47% year-over-year to $14.1 million. The company ended the period with $69 million in cash, cash equivalents and investment securities. MicroVision noted that it also has access to $143.4 million of capital through its at-the-market facility and convertible note facility. 
&#8220;MicroVision is well-positioned to secure revenue opportunities for 2025 from the industrial vertical,&#8221; said Sumit Sharma, CEO of MicroVision. &#8220;Our unique value proposition continues to be our integrated perception software. We offer compelling solutions to industrial customers and automotive OEMs at attractive price points.&#8221;
MicroVision said its production commitment with ZF enables the company to commit to high-volume deliveries to fulfill demand in the range of $30 million to $50 million over the next 12 to 18 months. 
The company also highlighted the establishment of a defense industry advisory board in the quarter that aims to accelerate strategic expansion and pursuit of revenue opportunities in the defense tech and military sectors.
Executives are currently discussing the quarter on a conference call that kicked off at 4:30 p.m. ET. The company also plans to hold an Investor Day on May 20. 
MVIS Price Action: <a href="http://benzinga.com/quote/mvis">MicroVision shares</a> were down 15.72% after-hours at 83 cents at the time of publication Monday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a> data.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/earnings/25/05/45361467/archer-aviation-reports-smaller-than-expected-loss-in-q1-company-says-uae-launch-remains-on-track-for-2025-shares-surge">Archer Aviation Reports Smaller-Than-Expected Loss In Q1, Company Says UAE Launch Remains &#8216;On Track&#8217; For 2025, Shares Surge</a></li>
</ul>
Photo: courtesy of MicroVision.

Movers

MVIS

MicroVision Stock Tumbles On Q1 Earnings Miss, Company Highlights Industrial Revenue Opportunities, Targets Defense Tech, Military Expansion

CTRI

Centuri Holdings Files For Mixed Shelf Of Up To $500M

ClearPoint Neuro, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLPT#NASDAQ">CLPT</a>) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced that it has entered into a note financing arrangement with Oberland Capital Management LLC ("Oberland Capital") of up to $105 Million, with $30.0 million of gross proceeds funded at closing. Additional note financing will be provided to the Company by Oberland Capital under the following terms:
An additional $25.0 million at the option of the Company any time prior to December 31, 2026; and
An additional $50.0 million at the option of the Company and Oberland Capital any time prior to December 31, 2026.
In addition to the note financing, the Company entered into a stock purchase agreement with Oberland Capital whereby Oberland Capital purchased 275,808 shares of the Company's common stock at a price of $12.69 per share in a registered direct offering, representing an additional $3,500,003.52 of gross proceeds to the Company. The price per share was equal to the trailing 30-trading days volume-weighted average price for the period ending on the day prior to the date of the stock purchase agreement. Oberland Capital also has the right to participate in a future offering of the Company's common stock in an amount of $1.5 million on or before December 31, 2026.

CLPT

ClearPoint Neuro Secures Up To $105M In Note Financing From Oberland Capital With $30M Funded At Closing, Gains Additional $3.5M Through Direct Stock Sale At $12.69/Share, And Retains Option For $75M More Plus Future $1.5M Equity Participation Through 2026

Barclays analyst Julian Mitchell maintains Regal Rexnord (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RRX#NYSE">RRX</a>) with a Overweight and raises the price target from $155 to $160.

Barclays Maintains Overweight on Regal Rexnord, Raises Price Target to $160

Village Farms Intl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VFF#NASDAQ">VFF</a>) reported quarterly losses of $(0.06) per share which missed the analyst consensus estimate of $(0.01) by 500 percent. This is a 100 percent decrease over losses of $(0.03) per share from the same period last year. The company reported quarterly sales of $77.07 million which beat the analyst consensus estimate of $76.28 million by 1.04 percent. This is a 1.28 percent decrease over sales of $78.08 million the same period last year.

Earnings Beats

Village Farms Intl Q1 EPS $(0.06) Misses $(0.01) Estimate, Sales $77.07M Beat $76.28M Estimate

<a href="https://www.bloomberg.com/news/articles/2025-05-12/amc-to-slash-movie-ticket-prices-by-50-on-wednesdays?embedded-checkout=true">https://www.bloomberg.com/news/articles/2025-05-12/amc-to-slash-movie-ticket-prices-by-50-on-wednesdays?embedded-checkout=true</a>

General

'AMC to Slash Movie Ticket Prices by 50% on Wednesdays'- Bloomberg

Barclays analyst Julian Mitchell maintains Kennametal (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMT#NYSE">KMT</a>) with a Equal-Weight and raises the price target from $22 to $24.

Barclays Maintains Equal-Weight on Kennametal, Raises Price Target to $24

BSLK

Bolt Projects Holdings Sees FY2026 Revenue To Be At Least $9M

Microvast Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MVST#NASDAQ">MVST</a>) affirms FY2025 sales outlook from $450.00 million-$475.00 million to $450.00 million-$475.00 million vs $462.97 million estimate.

MVST

Microvast Holdings Affirms FY2025 Sales Guidance of $450.00M-$475.00M vs $462.97M Est

Bolt Projects Holdings Sees FY2025 Revenue Of Atleast $4.5M

Copart (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CPRT#NASDAQ">CPRT</a>) has outperformed the market over the past 15 years by 12.98% on an annualized basis producing an average annual return of 24.58%. Currently, Copart has a market capitalization of $60.14 billion. 
Buying $100 In CPRT: If an investor had bought $100 of CPRT stock 15 years ago, it would be worth $2,674.99 today based on a price of $62.25 for CPRT at the time of writing.
<h3>Copart's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1747084514_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

CPRT

If You Invested $100 In This Stock 15 Years Ago, You Would Have This Much Today

Village Farms International Announces Transformative Transaction to Privatize Its Fresh Produce Business; Village Farms' Fresh Segment To Become Cornerstone Of Newco's Commercial Operations And Growth Strategy; Expects To Receive $40M In Cash Proceeds; 37.9% Equity Ownership Interest In Newco; Retains Ownership Of All Canadian Cultivation Assets

Bolt Projects Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BSLK#NASDAQ">BSLK</a>) reported quarterly losses of $(3.00) per share. This is a 89.37 percent increase over losses of $(28.22) per share from the same period last year. The company reported $171.00 thousand in sales this quarter. This is a 800.00 percent increase over sales of $19.00 thousand the same period last year.

Bolt Projects Holdings Q1 EPS $(3.00) Up From $(28.22) YoY, Sales $171.00K Up From $19.00K YoY

Central Puerto (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CEPU#NYSE">CEPU</a>) reported quarterly earnings of $0.50 per share. This is a 150 percent increase over earnings of $0.20 per share from the same period last year. The company reported $196.00 million in sales this quarter. This is a 130.67M percent increase over sales of $150.00 the same period last year.

CEPU

Central Puerto Q1 EPS $0.50 Up From $0.20 YoY, Sales $196.00M Up From $150.00 YoY

Barclays analyst Adrienne Yih maintains Victoria's Secret (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VSCO#NYSE">VSCO</a>) with a Overweight and lowers the price target from $38 to $23.

VSCO

Barclays Maintains Overweight on Victoria's Secret, Lowers Price Target to $23

Legacy Housing (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LEGH#NASDAQ">LEGH</a>) reported quarterly earnings of $0.43 per share which missed the analyst consensus estimate of $0.57 by 24.56 percent. This is a 28.33 percent decrease over earnings of $0.60 per share from the same period last year. The company reported quarterly sales of $35.70 million which missed the analyst consensus estimate of $43.13 million by 17.23 percent. This is a 17.44 percent decrease over sales of $43.24 million the same period last year.

LEGH

Legacy Housing Q1 EPS $0.43 Misses $0.57 Estimate, Sales $35.70M Miss $43.13M Estimate

Press Releases

Ioneer's Rhyolite Ridge Project Clears Major U.S. Federal Permitting Step, Advances Toward Construction

Ioneer's Rhyolite Ridge Lithium-Boron Project Receives Final Permit Approval from U.S. Federal Government; Construction Planned for 2025

Rhyolite Ridge Lithium-Boron Project Closes Upsized $996 Million Loan From U.S. Department of Energy to Accelerate Domestic Critical Mineral Production

American Battery Technology Company - Common Stock

American Battery Tech

BHP Group Limited American Depositary Shares (Each representing two Ordinary Shares)

Comments

Ioneer

매도 수량

Ioneer (NASDAQ:IONR) 주식, 공매도 수량 보고

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌